Advertisement

Topics

BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

08:00 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS® Control Unit 4.0. The EKOS® system includes an ultrasonic device th...

Other Sources for this Article

BTG
Hayley Senior, Media Relations Manager
+44 (0)20 7575 1582; Mobile: +44 (0)7815 778 536
or
Chris Sampson, Corporate Communications Director
+44 (0)20 7575 1595; Mobile: +44 (0)7773 251 178
or
Greentarget Communications
Chris Gale, Vice President
+1-646-695-2883; Mobile: +1-203-570-4681

NEXT ARTICLE

More From BioPortfolio on "BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...